<div><div><h2>Ajanta Pharma climbs 5% on USFDA approval for generic of Vesicare</h2></div><div>"moneycontrol newsajanta pharma shares gained more than 5 percent intraday friday on approval from the us health regulator for generic of vesicare.the pharma company has received tentative approval from the us food and drug administration for the generic of vesicare.vesicare is used for the treatment of overactive bladder with symptoms of urgency frequency and leakage.at 12:20 hours ist the stock was quoting at rs 1130.60 up rs 47.30 or 4.37 percent on the bse.the scrip gained nearly 10 percent in last one month but corrected nearly 20 percent in nine months."</div></div>